coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Care Kent PCN, Thanet · Health Inequalities Profile

    PCN U67045 · NHS Kent and Medway Integrated Care Board · 6 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    31,386

    Registered population

    54.4% aged 18–64

    28.7%

    Aged 65+

    ICB 19.9% · England 17.9%

    4.6%

    Ethnic minority (non-White)

    1.7% Asian · England 9.6%

    2.6%

    In IMD quintile 1

    ICB 17.1% · England 21.0%

    ~749

    Core20 residents (est.)

    Resident basis; registered basis ~3,625 · see page 3

    10,795

    Hypertension register

    +3.39% in 3 yrs · England +5.60%

    474

    SMI register

    26.1% of Thanet's

    1,656

    COPD register

    Reviews +4.71% in 3 yrs

    Forecast to 2030

    7,292

    Hypertension patients, 2030

    +-3,503 on today

    73.7%

    QRISK ≥20% on statins, 2030

    +4.42pp over 3 yrs

    7.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    -24.3%
    Heart failure reviews fell behind England.

    Functional reviews fell 24.3% from 2023 to 2025 (England +8.7%), reaching 71.7% against England's 78.5%, which may reflect recall gaps.

    7.4 pp
    Age-five MMR second-dose coverage gap.

    Q1 2025/26 age-five MMR coverage is 95.8% for dose 1 versus 88.4% for dose 2, reaching a 15 pp gap at Birchington Medical Centre.

    70.8%
    Asthma review coverage exceeds national benchmark.

    Annual asthma reviews rose +8.9% (2023 to 2025) to 70.8%, above England's 65.7%, though a modelled 957 patients remain unreviewed.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Patients aged 65+ make up 28.7% of the list alongside 33 catchment care homes

    Patients aged 65+ make up 28.7% (9,010) of CARE KENT PCN's 31,386 registered list, well above Thanet (23.6%), NHS Kent and Medway ICB (19.9%) and England (17.9%). Working-age adults (18–64) represent 54.4% (17,076; Thanet 57.7%, ICB 59.5%, England 62.7%), and children aged 0–17 comprise 16.9% (5,300; Thanet 18.7%, ICB 20.7%, England 19.6%). Census estimates show 95.4% White residents (Thanet 93.0%, ICB 88.6%, England 81.1%), leaving a 4.6% ethnic minority share. Practice lists sum to 49,023, creating an unreconciled gap against the 31,386 PCN list base.

    Age profile

    0–1716.9%
    18–6454.4%
    65+28.7%

    65+: ICB 19.9%, England 17.9%

    Ethnicity

    White95.4%
    Mixed1.8%
    Asian1.7%
    Other0.7%
    Black0.5%

    Older people · falls rows are Thanet local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Thanet LA)1,8892,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)85.2%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)59.0%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Thanet LA)9889819552024/25
    Falls deaths, all ages, per 100,000 (Thanet LA)25.414.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN Core20 deprivation is 2.6% overall but reaches 19.8% at Birchington Medical Centre

    CARE KENT PCN's Core20 cohort is 2.6%, below Thanet (36.8%), NHS Kent and Medway ICB (17.1%) and England (21.0%). Practice Core20 shares span a 19.8 pp range: Birchington Medical Centre records 19.8%, while Ash Surgery records 0.0%. Population bases diverge before targeting: associated LSOA estimates yield 749 Core20 residents, while practice registered shares average 7.4% and sum to 3,625 patients, led by 2,518 at Birchington Medical Centre. Concentrated deprivation at Birchington Medical Centre may indicate uneven demand, which address-level practice audits would test once resident and registered denominators are reconciled.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Birchington19.8% · 2,518 patients
    St Peter's7.4% · 364 patients
    Broadstairs5.3% · 389 patients
    Minster2.3% · 216 patients
    Westgate1.4% · 138 patients
    Ash0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    474

    SMI register

    0.97% recorded prevalence

    322

    Learning disability register

    0.66% recorded prevalence

    33

    Care homes, 1,017 beds

    In the PCN catchment

    10.3%

    Provide unpaid care

    Thanet, Census 2021

    Learning disability prevalence is 0.7% (322 patients; Thanet 0.7%, ICB 0.6%, England 0.6%), and severe mental illness is 1.0% (474 patients; Thanet 1.2%, ICB 0.9%, England 1.0%). The PCN catchment holds 33 care homes with 1,017 beds. These recorded registers and catchment care home beds are consistent with clinical demand for annual reviews, which practice workload audits would test.

    Severe mental illness: physical health checks

    SMI blood pressure checks reached 84.7% (England 83.4%), but BMI recording was 81.9% (England 82.1%) and alcohol recording in psychosis was 76.1% (England 81.8%). Full health checks cannot be assumed across the register.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,795

    Hypertension register

    +3.39%

    Register growth, 3 yrs

    Thanet +2.67% · England +5.60%

    −1.12pp

    BP control, under 80

    ≤140/90 · +2.89pp aged 80+

    −3,503

    More patients by 2030

    Forecast 7,292 (22.38%)

    Hypertension case-finding and control

    Hypertension register prevalence is 22.1% (10,795 patients), above Thanet (18.8%), NHS Kent and Medway ICB (16.2%) and England (15.2%). This crude rate is consistent with an older population (28.7% aged 65+) and implies a base of 48,846 rather than the 31,386 list. While blood pressure control at age 80+ reached 82.8% (England 81.2%), under-80 control fell 1.7% over 2023 to 2025 (England +3.2%) to 65.7% (England 67.8%). Heart failure reviews also fell 24.3% over 2023 to 2025 (England +8.7%) to 71.7% (England 78.5%). Falling under-80 blood pressure control and heart failure reviews may reflect recall gaps, which proactive clinical audits could test.

    Lipids and statins

    Statin therapy in diabetes with CVD is 80.4% (Thanet 81.7%, NHS Kent and Medway ICB 83.3%, England 84.4%). For patients with QRISK ≥ 20%, lipid-lowering coverage is 62.8% (England 63.6%). Lower secondary prevention coverage indicates a need to audit high-risk prescribing protocols across practices.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202666,269£1.70£1.90£1.86£112,657
    Cardiovascular (all), 202584,280£2.99£3.57£3.33£251,997

    In 2026, the PCN prescribed 66,269 lipid-regulating items at £1.70 per item, below Thanet (£2.10), NHS Kent and Medway ICB (£1.90) and England (£1.86). Across these items, the PCN spent £10,603 less than at England's unit cost. Lower unit cost does not establish clinical efficiency, which formulary and dosage reviews could test.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +8.86%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +2.77%

    Asthma prevalence, PCN 3-yr % change

    COPD prevalence is 3.4% (England 1.9%, Thanet 3.2%) and asthma prevalence is 7.0% (England 6.6%). Annual review rates exceed England for COPD (80.7% vs 76.4%) and asthma (70.8% vs 65.7%), though a modelled 957 asthma patients lack a recorded review on a 3,273 register. Asthma prescribing among children aged 5–19 is 1,836 items per 1,000 (England 1,488; Thanet 2,012), while second-hand smoke recording is 75.1% (England 78.8%), which clinical audits could assess.

    Cancer register and children's immunisation

    Cancer register prevalence is 6.6% (3,230 patients), above England (3.8%) and Thanet (5.1%). In Q1 2025/26 childhood immunisation, age-five MMR dose 1 coverage reached 95.8%, but dose 2 was 88.4%—a 7.4 pp same-cohort difference that is 6.6 pp below the 95.0% target, reaching 15 pp at Birchington Medical Centre. Recall audits could test whether pre-school reminder workflows explain the second-dose gap.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months90.9%

    England 91.0%

    6-in-1 complete primary course at 24 months93.8%

    England 92.2%

    MMR dose 1 at 24 months87.5%

    England 88.3%

    MMR dose 2 at age 588.4%

    England 82.8%

    4-in-1 pre-school booster at age 590.5%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Kent and Medway ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,630

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Kent and Medway ICBEnglandNo usable stageStaged cancers
    Breast82.1%85.4%23%1,509
    Prostate54.4%53.2%37%1,435
    Lung29.4%33.8%21%1,109
    Bowel48.2%47.0%29%1,013
    Skin cancer87.5%87.8%23%562

    In 2022, 55.6% of staged cancers in NHS Kent and Medway ICB (4,661 of 8,384) were diagnosed at stage 1 or 2 (England 55.3%), trailing the 75.0% national ambition. Known-stage completeness was 63.6% (8,384 of 13,189; England 67.0%). Across the ICB, reaching 75.0% would require 1,627 extra early-stage diagnoses annually. Early detection was 29.4% in lung (England 33.8%) and 48.2% in bowel (England 47.0%). At PCN level, cancer register growth was +5.8% (2023 to 2025), trailing England (+9.0%), with Minster Surgery at +1.4% and Ash Surgery at +3.3%. ICB staging describes the wider system, not PCN performance.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026 (provisional), East Kent Hospitals University NHS Foundation Trust met the 31-day cancer standard at 96.7% (standard 96.0%; NHS Kent and Medway Integrated Care Board 95.8%, England 92.5%). However, it trailed on 28-day faster diagnosis at 71.3% (standard 75.0%; ICB 76.8%, England 79.3%) and 62-day treatment at 70.0% (standard 85.0%; ICB 75.9%, England 71.2%). Medway NHS Foundation Trust reached 81.6% and Mid and South Essex NHS Foundation Trust 50.2% on 62-day waits. At East Kent Hospitals, 47.6% waited 6+ weeks for MRI (England 21.4%) and 37.4% for CT (England 9.9%).

    Pathways within standard (%)East KentMid and South EssexMedwayKent and Medway ICBEngland
    28-day faster diagnosis (75%)71.2867.4577.7776.7879.32
    31-day treatment (96%)96.6781.8899.6295.8492.50
    62-day referral to treatment (85%)70.0150.2581.6475.9371.16
    Diagnostic waits over 6 weeks (%)East KentMid and South EssexMedwayEngland
    MRI47.5823.350.6821.40
    CT37.456.070.009.92
    Echocardiography14.1765.0536.6228.48
    Colonoscopy9.5864.091.8830.83
    Gastroscopy22.1659.763.3229.02
    All 15 DM01 tests48.3841.5414.2023.14
    Community services activityKent residentsKent and Medway ICB
    Care contacts210,170254,055
    Referrals59,36068,085
    Patients with a contact60,60572,060

    Community services (residents of Kent), Jun 2026 (provisional). In June 2026 (provisional), community health service activity for Thanet residents recorded 210,170 total contacts. Adults aged 65 and over accounted for 138,250 of these contacts, representing 65.8% of all borough community activity. These figures reflect borough resident contacts rather than PCN-specific delivery, consistent with substantial older-age use of local community care.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice phone access spans 33.7 pp and overall experience varies by 21.7 pp

    In 2025/26, QOF overall achievement ranged from 77.6% at Ash Surgery to 94.7% at Minster Surgery, against an England sum of 92.5%. Vaccination and immunisation achievement showed a 45.5 pp spread, from 21.7% at St Peter's Surgery to 67.2% at Ash Surgery. These variations may reflect differing practice recall systems, which administrative audits could test.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Westgate Surgery1211.474.8%72.2%91.3%
    Broadstairs1085.381.5%62.0%80.2%
    Minster Surgery1112.359.4%64.8%76.6%
    Ash Surgery1080.049.8%69.2%73.0%
    Birchington11219.847.7%72.6%71.4%
    St Peter's Surgery887.461.7%78.0%69.6%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNThanetAssetPCNThanet
    Care homes (catchment)33 (1,017 beds)n/aSchools (catchment)63n/a
    Children's centres59Places of worship6984
    Libraries56Day centres (VCS)914
    Children and young people (VCS)13Carers support groups (VCS)24
    Primary schools (LA maintained)1816Primary academies414
    Special schools12

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Pre-school MMR second-dose recall

    In Q1 2025/26, age-five MMR coverage had a 7.4 pp gap between dose 1 (95.8%) and dose 2 (88.4%, below the 95.0% target by 6.6 pp), reaching 15 pp at Birchington Medical Centre. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Option 2

    Core20 denominator and access audit

    Weighted practice Core20 is 7.4% (3,625 estimated patients, including 2,518 at Birchington Medical Centre at 19.8%) versus 2.6% at PCN level (749 residents; England 21.0%). For discussion: the PCN could reconcile registered addresses against IMD deciles 1 and 2 and review phone access and recall at the highest-share practices. Moderate effort to run.

    Evidence base: the share of patients in the most deprived quintile is the Core20 targeting measure used to weight inequalities funding, outreach and prevention capacity, and the gradient every clinical indicator should be read against.

    Policy anchor: Core20PLUS5 (Core20 = the most deprived 20% by IMD); 10 Year Health Plan, with widening inequalities the equity test of reform.

    Option 3

    Structured asthma review and smoke recording

    Although asthma reviews rose +8.9% (2023 to 2025) to 70.8% (England 65.7%, Thanet 58.7%), a modelled 957 of 3,273 registered patients lack a review. For discussion: practices could run a single asthma recall template that prompts second-hand smoke recording alongside inhaler prescribing checks. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult capacity list reconciliation (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Targeted Core20 list reconciliation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check audit (p4)SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN
    Under-eighty blood pressure recall (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool MMR recall audit (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cancer register and referral audit (p7)Cancer: QOF prevalenceCore20PLUS5, 75% stage 1–2 by 2028PCN
    Practice telephony and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Pre-school MMR second-dose recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Option 2 · Core20 denominator and access audit (p12)Core20 cohort (IMD quintile 1) · GPPS easy to contact the practice by phoneCore20PLUS5 · 10YHP equity test · 10YHP, hospital to communityPCN & Practice
    Option 3 · Structured asthma review and smoke recording (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15